跳至主要内容
临床试验/NCT03872635
NCT03872635已完成不适用

Effects of Drug or Drink Intervention and Temperature Protectionon for Cervical Cancer Patients on Insulin Resistance and Tumor Immunity

Fujian Cancer Hospital2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
2
主要终点
insulin resistance

研究概览

简要总结

To evaluate the effects of preoperative oral carbohydrate on postoperative insulin resistance and tumor immunity in cervical cancer patients with neoadjuvant chemotherapy.

详细描述

Fifty-one patients undergoing neoadjuvant chemotherapy and radical hysterectomy with bilateral pelvic lymph node dissection were randomized to receive 300mL of an oral carbohydrate liquid supplement 2 hour before surgery(CHO group) or to fast on standard hospital protocol (8 hour fasting for solid and 4 hour fasting for clear liquid)(FAST group).According to inclusion and exclusion standards, twenty-six patients undergoing the same surgery and standard fasting were selected as control group. Baseline and postoperative measurements of insulin sensitivity were assessed in term of fasting plasma glucose(FPG),fastingainsulin(FINS),HOMA-insulinaresistance(HOMA-IR),HOMA-insulin secretion function index(HOMA-IX) , HOMA-beta cell function index(HOMA-β),serum C-peptide and glucagon.Baseline and postoperative measurements of tumor immunity were evaluated using NK cell and T-cell dynamics.VAS score was introduced to assess preoperative comfort.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •The patients aged from 18 to 60 years old were ASA level I to II, and the informed consent was signed by the patients, which was approved by the ethics committee of the hospital.
  • •Cervical squamous cell carcinoma was confirmed by cervical biopsy before pathologic surgery. CT showed no distant metastasis. All patients underwent total hysterectomy, bilateral adnexectomy and pelvic lymph node dissection.
  • •Fasting blood glucose was normal without diabetes, impaired glucose tolerance or other metabolic diseases.
  • •no gastric emptying dysfunction.

排除标准

  • •Patients with obstruction of gastric emptying, such as pyloric obstruction, gastroesophageal reflux, nausea and vomiting, etc
  • •Obese (BMI >32) or severely malnourished (BMI<18.5)
  • •Distant metastasis, multiple primary cancers and recurrent tumors
  • •Patients with functional disorders of respiratory system, circulatory system, immune system, nervous system, urinary system and other organs
  • •Received blood transfusion and nutritional support within 2 weeks before surgery
  • •The supplement contains the sugar solution, the blood transfusion, the application glucocorticoid, the sympathetic blood vessel activity medicine in the operation.

研究组 & 干预措施

CHO Drinking Grope

Experimental

receive 300mL of an oral carbohydrate liquid supplement 2 hour before surgery

干预措施: oral carbohydrate liquid (Other)

Traditional fast Grope

No Intervention

fast on standard hospital protocol (8 hour fasting for solid and 4 hour fasting for clear liquid

结局指标

主要结局

insulin resistance

时间窗: in 24 hrs

The patient's insulin resistance was determined by fasting plasma glucose(FPG),fastingainsulin(FINS), andHOMA-IR=FPG(mmol/L)×FINS(mIU/L)/22.5

次要结局

  • tumor immunity(in 24 hrs)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验